Investor · New Canaan, CT
Joseph J. Rucci
Open Joseph in the network graph →Filings
19
SEC Form D
Connections
45
co-filers
Capital
$4.2M
across filings
Active
Jan 2015
to Feb 2024
Most-connected co-filers (45)
Ronan T. Guilfoyle · Grand Cayman, Cayman Islands11 sharedVince L. Tyra · Louisville, KY7 sharedAlan L. Schroering · Louisville, KY7 sharedOrson L. Oliver · Louisville, KY7 sharedTobam · Paris, I07 sharedTheodore W. Maione · Troy, NY7 sharedC. D. Maglaris · New Canaan, CT6 sharedRonald L. Strecker · Louisville, KY6 sharedSean L. Garber · Louisville, KY6 sharedTrevor Kienzle · San Diego, CA5 sharedDavid Coats · San Diego, CA5 sharedGrace Chui-Miller · San Diego, CA5 sharedWeiss Multi-Strategy Advisers LLC · Hartford, CT5 sharedEduardo Juan · Carmel, IN5 sharedRobert Knorr · Carmel, IN5 sharedJames E. Tyree · Carmel, IN5 sharedConor J. Walshe · CAMBRIDGE, MA5 sharedMichael R. Healy · Owings Mills, MD5 sharedTobam · Paris, I05 sharedBertrand Gibeau · Grand-Duchy of Luxembourg, Luxembourg5 sharedYves Choueifaty · Paris, I05 sharedCary M. Marr · Grand Cayman, Cayman Islands5 sharedFrederick W. Telling · Port Orange, FL5 sharedAnu Pathria · San Diego, CA5 shared
Recent filings (19)
TOBAM Anti Benchmark Emerging Markets Equity Fund, a series of Most Diversified Portfolio SICAVFeb 2024 · 13 co-filersCytogel Pharma, LLCMar 2021 · 9 co-filers$25.0MCytogel Pharma, LLCMar 2020 · 12 co-filers$25.0MCytogel Pharma, LLCMar 2019 · 14 co-filers$200KTOBAM Anti Benchmark Emerging Markets Equity Fund, a series of Most Diversified Portfolio SICAVMar 2019 · 12 co-filersTOBAM Anti Benchmark Emerging Markets Equity Fund, a series of Most Diversified Portfolio SICAVJul 2018 · 7 co-filersCytogel Pharma, LLCMay 2018 · 11 co-filers$3.0MTOBAM Anti Benchmark Emerging Markets Equity Fund, a series of Most Diversified Portfolio SICAVJul 2017 · 7 co-filersCorrelation Ventures II, L.P.Jul 2016 · 10 co-filers$187.8MTOBAM Anti Benchmark Emerging Markets Equity Fund, a series of Most Diversified Portfolio SICAVMar 2016 · 12 co-filersCorrelation Ventures II, L.P.Mar 2016 · 10 co-filers$170.0MCorrelation Ventures Executives Fund II, L.P.Mar 2016 · 10 co-filers$7.0MTOBAM Anti Benchmark Emerging Markets Equity Fund, a series of Most Diversified Portfolio SICAVApr 2015 · 12 co-filersCorrelation Ventures II, L.P.Mar 2015 · 10 co-filers$170.0MCorrelation Ventures Executives Fund II, L.P.Mar 2015 · 10 co-filers$5.0MTOBAM Anti Benchmark Emerging Markets Equity Fund, a series of Most Diversified Portfolio SICAVMar 2015 · 12 co-filersCytogel Pharma, LLCJan 2015 · 8 co-filers$8.0MCytogel Pharma, LLCMar 2014 · 9 co-filers$1.1MCytogel Pharma, LLCMay 2010 · 4 co-filers$2.2M
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Joseph in the interactive graph →